Skip to main content

Author: Bill Snyder

MEGAMicrobe event to explore world of microbes Sept. 17

Aug. 31, 2022—Families, parents, teachers, and students are invited to explore the world of microbes during a free hands-on event from 9 a.m.to 2 p.m. Saturday, Sept. 17, at the Warner Elementary Arts Magnet School, 626 Russell Street in East Nashville. Hosted by the Vanderbilt Institute for Infection, Immunology and Inflammation (VI4) in partnership with Nashville Parent...

Read more


Study describes how E. coli co-opts cells, causes recurrent UTIs

Aug. 25, 2022—Researchers at Vanderbilt University Medical Center have discovered why the uropathogenic bacterium E. coli, the leading cause of urinary tract infections, is so tenacious; their findings could lead to new ways to prevent recurrent UTIs.

Read more


Rheumatoid arthritis and heart disease: a common path

Aug. 25, 2022—An increase in certain antibodies in patients with rheumatoid arthritis can serve as a predictive biomarker for cardiovascular disease, Vanderbilt researchers have discovered.

Read more


COVID antibody research conducted at VUMC lands national award

Aug. 24, 2022—A long-acting antibody combination discovered at Vanderbilt University Medical Center that protects against COVID-19 in high-risk individuals has received a gold medal in the 2022 R&D 100 awards program announced Aug. 22 by R&D World Magazine.

Read more


Study seeks to explore drug link to fetal vessel defect

Aug. 18, 2022—Vanderbilt researchers have received a grant to study whether drugs given to premature infants in the neonatal intensive care unit (NICU) contribute to a potentially lethal condition called patent ductus arteriosus.

Read more


Vanderbilt Prize winner Lehmann’s Discovery Lecture postponed

Aug. 17, 2022—Ruth Lehmann, PhD, recipient of the 2022 Vanderbilt Prize in Biomedical Science, will deliver her Vanderbilt Prize Discovery Lecture at 4 p.m. Thursday, Sept. 1, in 208 Light Hall.

Read more


Nanoparticles boost anti-cancer immunity

Aug. 16, 2022—An ingenious targeted nanoparticle approach developed by Vanderbilt researchers reduced tumor burden in a model of ovarian cancer.

Read more


Science career “pipeline” garners national attention

Aug. 3, 2022—Vanderbilt's Aspirnaut STEM pipeline for diversity and wellness recently celebrated its 15th anniversary with a daylong scientific symposium, followed by a feature on the program broadcast Aug. 2 on NBC Nightly News.

Read more


Embryo screening for mental illness questioned

Aug. 3, 2022—Report finds polygenic embryo screening (PES) does not provide an accurate measure of the risk of developing psychiatric disorders later in life.

Read more


Video vital for telehealth visits

Jul. 28, 2022—Vanderbilt study of 18,130 telehealth visits at the beginning of the COVID-19 pandemic defines risk factors associated with telehealth access and suggests how health systems can improve access.

Read more


C. difficile may contribute to colorectal cancer: study

Jul. 28, 2022—A Vanderbilt study found that the bacterium Clostridioides difficile (C. difficile) may be a previously unrecognized contributor to colorectal cancer.

Read more


Difficulty swallowing linked to chronic opioid use: study

Jul. 21, 2022—Vanderbilt researchers found that chronic use of opioid painkillers like hydrocodone and oxycodone significantly increases the risk of dysphagia, or difficulty swallowing.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more